Refine by
Applications
- microbiota for Clinical Studies
- Intraoperative Radiation Therapy (IORT) System - Electron Therapy for Skin Cancer
- Intraoperative Radiation Therapy (IORT) System for Flash Radiotherapy
- Intraoperative Radiation Therapy (IORT) System for Pancreatic Cancer Treatment
- Intraoperative Radiation Therapy (IORT) System for Breast Cancer Treatment
- Intraoperative Radiation Therapy (IORT) System for Single-Fraction APBI
- Intraoperative Radiation Therapy (IORT) System for Surgical Oncologists
- Intraoperative Radiation Therapy (IORT) System for Radiation Oncologists
- Intraoperative Radiation Therapy (IORT) System for Hospital Administrators
- Solution for Clinical Trials
- Solution for Access to Investigational Medicines
- Radioactive Drugs for Diagnostics
- Radioactive Drugs for Therapeutics
- Medical Devices for Medical Professionals
- Medical Devices for Patients
- Medical Devices for Chronic Venous Insufficiency: Eliminating Pain
- Medical Devices for Breast Cancer-Related Lymphedema
- Medical Devices for Lipedema
Cancers Of The Breast Equipment & Supplies
341 equipment items found
Manufactured by:Precirix based inBrussels, BELGIUM
This targeted radioligand therapy is being developed for the treatment of patients with metastatic HER2-positive cancer indications, such as breast and gastric adenocarcinoma. In addition to the company’s lead program, two product candidates for undisclosed oncology targets are entering IND-enabling initiatives. PRECIRIX’ preclinical programs further ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Apomine (SR-45023A) is an antineoplastic agent that inhibits the mevalonate/isoprenoid pathway in cholesterol synthesis.Apomine can accelerate the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR). Apomine can also inhibit the growth of various types of cancer cells, including lung cancer, colon cancer, breast ...
Manufactured by:SEQENS Group based inÉcully, FRANCE
Anastrozole is a competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of postmenopausal women with estrogen-responsive breast ...
Manufactured by:Prestige Ameritech based inNorth Richland Hillsq, TEXAS (USA)
Our Pink Ribbon Masks will let everyone know that you are part of the effort to raise breast cancer awareness this October. ...
Manufactured by:Caprico Biotechnologies, Inc. (CBI) based inNorcross, GEORGIA (US) (USA)
Predictive or prognostic factor in metastatic breast ...
Manufactured by:Taiho Oncology, Inc. based inPrinceton, NEW JERSEY (USA)
Colorectal cancer in combination with bevacizumab PHASE ...
Manufactured by:Cerca Biotech based inBerlin, GERMANY
MKI67 protein is present during all active phases of the cell cycle (G1, S, G2, and mitosis), but is absent from resting cells (G0). In Breast Cancer MKI67 expression is a prognostic marker for survival and tumour ...
Manufactured by:S1 Biopharma, Inc. based inNew York City, NEW YORK (USA)
It is not uncommon for medical conditions to be accompanied by low desire. For example, low desire affects 90% of patients with breast cancer and 50% of those with ...
by:Cymit Química S.L. based inBarcelona, SPAIN
4-Methylumbelliferyl lignocerate is a synthetic fatty acid that inhibits the growth of cancer cells. It has been shown to have an inhibitory effect on breast cancer cell lines, such as MDA-MB-231 and MCF-7. ...
Manufactured by:Cerca Biotech based inBerlin, GERMANY
It is a transcription factor regulating the expression of genes and is activated by estrogen. Estrogen receptors are overexpressed in about 70 % of all Breast Cancer cases. There are hypotheses, that overexpression causes tumourigenesis. ESR1 overexpressing tumours can be treated with endocrine therapies such as tamoxifen (ESR anatagonist) or anastrozol ...
Manufactured by:The Electrospinning Company Ltd. based inDidcot, UNITED KINGDOM
The thickness of Mimetix scaffold allows for having a 3D environment while maintaining a certain translucence, thus allowing for easy and robust imaging. This study has investigated the localisation depth of MCF7 breast cancer cells in the Mimetix scaffold after 4 days of culture (nuclei stained with TO-PRO-3, blue). The video below shows a Z-stack (slices ...
Manufactured by:Radiopharm Theranostics based inCarlton, AUSTRALIA
Pivalate is the invention of Professor Eric Aboagye of Imperial College London: Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilises the early steps of fatty acid oxidation and is very stable; In comparison to the clinical standard in PET imaging, 18F-FDG in prostate and brain cancers, Pivalate showed superior imaging performance and was equally ...
Manufactured by:ALL Chemistry Inc. based inMarlton, NEW JERSEY (USA)
Tetramethylcurcumin is a novel curcumin analog, is an effective inhibitors of STAT3 phosphorylation, DNA binding activity, and transactivation in vitro.it also inhibits colony formation in soft agar, cell invasion, and exhibit synergy with the anti-cancer drug doxorubicin against breast cancer ...
Manufactured by:Hebei Mirun Import and Export Trading Co., Ltd based inMinhang District, CHINA
Short Description: Ropivacaine hydrochloride monohydrate has been used as an analyte in tandem mass spectrometry and as an amide-based local anaesthetic to test its effect on breast cancer cell methylation. ...
Manufactured by:Shanghai Henlius Biotech, Inc based inShanghai, CHINA
(trastuzumab, Zercepac in the EU) was successfully launched in China and Europe, becoming the first Chinese mAb biosimilar entering both the EU and China market. It is indicated for the treatment of HER2 positive early breast cancer, metastatic breast cancer and metastatic gastric cancer, which corresponds to all ...
Manufactured by:Cerca Biotech based inBerlin, GERMANY
ERBB2 activation stimulates cell proliferation and inhibits programmed cell death. ERBB2 has an important role in Breast Cancer. About 20 % of all Breast Cancers show an overexpression of this receptor, which is associated with poor prognosis and clinical outcome. Patients with an ERBB2 overexpression can benefit from an ...
Manufactured by:OncoQR ML GmbH based inVienna, AUSTRIA
Lead candidate OQR200 is a new candidate against HER2/neu, the by far best characterized and clinically validated target to treat breast cancer indications. A reversible induction of HER2/neu specific antibodies has been demonstrated. In vitro, the immune response induced by OQR200 has been shown to have superior efficacy in a direct side by side comparison with ...
by:RaySearch Laboratories based inStockholm, SWEDEN
Save time and reduce the risk of error by automating treatment planning. Advanced plan-generating protocols, scripting, automated breast planning, fallback planning, machine learning and plan explorer are some of the tools available in RayStation — the first treatment planning system to incorporate machine learning applications. ...
Manufactured by:Cerca Biotech based inBerlin, GERMANY
Upon binding of progesterone, the receptor is activated and modifies expression of several downstream genes. Estrogen and progesterone receptors are found in Breast Cancer cells that depend on estrogen and related hormones (such as progesterone) to grow. All patients with invasive Breast Cancer or a Breast ...
Manufactured by:ACROBiosystems based inNewark, DELAWARE (USA)
Trastuzumab, is a monoclonal antibody used to treat breast cancer. Specifically it is used for breast cancer that is HER2 receptor positive. Trastuzumab works by binding to the HER2 receptor and slowing down cell duplication. Trastuzumab is a recombinant IgG1 kappa, humanized monoclonal antibody that selectively binds with high ...